Kyverna Therapeutics, Inc. KYTX · Insights

website

149

Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell t...

Price5.17

Market Cap314.34 M

Float50.42 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Key Dates & Timelines

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro

Financial Transactions

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro